Posted An over-the-counter drug, readily available to consumers for years, may open a new option for preventing colorectal cancer in high-risk individuals. It's not the mouse that roared but the quiet mouse behind the scenes that... Read More
POSTED: 02/03/2021
SOURCE: Cancer Prevention Science Blog
Early Detection Research Network Marks 20 Years
This month, the Early Detection Research Network (EDRN) marks its 20th anniversary. The National Cancer Institute (NCI) launched the network in 2000 with the goal of identifying and harnessing biomarkers as a way of... Read More
POSTED: 12/21/2020
SOURCE: AACR Cancer Research Cataylst Blog
As this unforgettable year of 2020 comes to an end, I am reaching the milestone of my first 6 months as Director of the NCI Division of Cancer Prevention (DCP). It has been a whirlwind of virtual meetings and introductions.... Read More
POSTED: 12/17/2020
SOURCE: Cancer Prevention Science Blog
The SWOG Cancer Research Network is opening to accrual the MiCHOICE Trial to study the use of decision support tools by women with high-risk breast conditions and their healthcare providers to choose among chemoprevention... Read More
POSTED: 12/08/2020
SOURCE: Cancer Prevention Science Blog
If you were concerned that you might be at increased risk for a specific kind of cancer, what would you do to confirm that risk, and what would you be willing to do to reduce that risk? The answer is likely to be, "it... Read More
POSTED: 11/19/2020
SOURCE: Cancer Prevention Science Blog
In a commentary written by several of its clinical scientific leaders, changes were proposed to the National Cancer Institute (NCI) clinical trials program to improve clinical trial availability, effectiveness, and diversity... Read More
POSTED: 11/16/2020
SOURCE: DCP News
RESEARCH UPDATE: ON THE CLINICAL FRONT A Metaproteomic Approach to Assessing Gut Microbial Protein Expression in Dietary Patterns Announcements The Transdisciplinary Research on Energetics and Cancer (TREC) Training... Read More
POSTED: 10/29/2020
SOURCE: DCP News
NCI Cancer Moonshotâ„ Biobank Launches Exclusively through 20 NCORP Sites
NCI has launched the Cancer Moonshotâ„ Biobank to procure and distribute longitudinal patient biospecimens for cancer research exclusively through 20 community research sites in the NCI Community Oncology Research Program (... Read More
POSTED: 10/19/2020
SOURCE: NCI DCTD News
Projects Making Progress in Breast Cancer Detection and Prevention, By: Philip E. Castle
In the month of October, breast cancer awareness is the health message that looms large. Yet, researchers across the National Cancer Institute and across the world are focused on breast cancer all the time. In the United... Read More
POSTED: 10/19/2020
SOURCE: Cancer Prevention Science Blog
The National Cancer Institute was directed by Congress "to develop, validate, improve, and implement serological testing and associated technologies" to characterize the immune responses elicited by SARS-CoV-2 viral... Read More
POSTED: 10/08/2020
SOURCE: DCP News
NCORP Annual Meeting Focuses on Clinical Trials, COVID-19 and Telemedicine
The impact of the COVID-19 pandemic on cancer research and clinical trials, and the growing use of telemedicine garnered much of the focus during Part 1 of the annual meeting of the NCI Community Oncology Research Program (... Read More
POSTED: 09/29/2020
SOURCE: NCI NCORP News
Research to uncover how and why benign gynecologic conditions like endometriosis or uterine fibroids progress to invasive and deadly ovarian cancer or uterine sarcomas, is a critical and overlooked issue in women’s health. A... Read More
POSTED: 09/28/2020
SOURCE: Cancer Prevention Science Blog
DCP Director Philip E. Castle, Ph.D., M.P.H. Coming on board as the Division of Cancer Prevention (DCP) Director in July 2020 was a unique challenge. COVID is a serious problem now, but we have faith in science that it... Read More
POSTED: 09/11/2020
SOURCE: DCP News
As the availability and sophistication of smart technology for health (such as wearables, sensors, and micro-robotic tools) continues to increase, these devices could prove transformative in cancer prevention. Two ongoing... Read More
POSTED: 09/08/2020
SOURCE: Cancer Prevention Science Blog
Regular Aspirin Use May Increase Older People’s Risk of Dying from Cancer
Numerous studies have suggested that people who regularly take low doses of aspirin may have reduced risks of being diagnosed with or dying from cancer. But new findings from a randomized clinical trial, called ASPREE,... Read More
POSTED: 08/18/2020
SOURCE: Cancer Currents Blog
RESEARCH UPDATE: ON THE CLINICAL FRONT Zinc Induces Potential Chemopreventive Activity in Barrett’s Esophagus Zinc’s chemopreventive activity for esophageal cancer has been well demonstrated in animal models. In humans,... Read More
POSTED: 07/30/2020
SOURCE: DCP News
Responding to Coronavirus, Cancer Researchers Reimagine Clinical Trials
When the coronavirus pandemic reached the United States, thousands of people with cancer were participating in clinical trials, including many at St. Jude Children’s Research Hospital in Memphis, Tennessee. At St. Jude,... Read More
POSTED: 06/29/2020
SOURCE: NCI Cancer Currents Blog
NIH scientists develop blood test to help improve liver cancer screening
Scientists have developed a new test that can help identify people who are likely to develop hepatocellular carcinoma (HCC), the most common form of liver cancer. The approach uses a simple blood test to check for the... Read More
POSTED: 06/11/2020
SOURCE: NCI Press Release
A new technology coupled with a new biomarker test now in clinical trials are giving patients timely access to a quick, accurate and less invasive way to identify risk for one type of esophageal cancer. EsoCheckâ„¢ and... Read More
POSTED: 06/01/2020
SOURCE: Cancer Prevention Science Blog
How Does COVID-19 Affect People with Cancer? NCCAPS Will Help Find Out
With the sudden explosion of the COVID-19 pandemic, we are all living with a great deal of fear, uncertainty, and anxiety. As an oncologist and cancer researcher, I know that those feelings are heightened for many people... Read More
POSTED: 05/21/2020
SOURCE: NCI Cancer Currents Blog
COVID-19 is an emerging, rapidly evolving situation. In addition to the information sources listed in the web header, the National Cancer Institute and the Division of Cancer Prevention have issued guidance for DCP... Read More
POSTED: 05/07/2020
SOURCE: DCP News
NCORP Partners in ACTIV Response to COVID-19
The National Institutes of Health and the Foundation for the NIH (FNIH) are bringing together more than a dozen leading biopharmaceutical companies, the Health and Human Services Office of the Assistant Secretary for... Read More
POSTED: 05/04/2020
SOURCE: NIH Press Release
Updated: July 9, 2020 NCI participated in the American Association for Cancer Research (AACR) Annual Meetings, held virtually on April 27 -Â 28, 2020 (Meeting I) and June 22 -Â 24, 2020 (Meeting II), including presenting the... Read More
POSTED: 04/29/2020
SOURCE: DCP News
RESEARCH UPDATE: ON THE CLINICAL FRONT No Association Between Vitamin D Supplementation and Risk of Colorectal Adenomas or Polyps Vitamin D has been associated with lower incidence and mortality of colorectal cancer, yet... Read More
POSTED: 04/23/2020
SOURCE: DCP News
Single Dose of HPV Vaccine Yields Long-Term Protection from Many Cancer-Causing Types
More than a decade after vaccination, women who had received a single dose of human papillomavirus (HPV) vaccine continued to be protected against cervical infection with the two cancer-causing HPV types targeted by the... Read More
POSTED: 04/10/2020
SOURCE: NCI Cancer Currents Blog
